Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More Advocacy at a Glance 10/24/20 Advocacy at a Glance 10/24/20 Washington Is Waiting for the Election Read More Analysis and Commentary 7/10/20 Analysis and Commentary 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Advocacy at a Glance 7/10/20 Advocacy at a Glance 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More Advocacy at a Glance 6/26/20 Advocacy at a Glance 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Advocacy at a Glance 4/24/20 Advocacy at a Glance 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More Analysis and Commentary 4/17/20 Analysis and Commentary 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More Advocacy at a Glance 4/17/20 Advocacy at a Glance 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More Advocacy at a Glance 3/27/20 Advocacy at a Glance 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More Advocacy at a Glance 10/5/19 Advocacy at a Glance 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More Advocacy at a Glance 8/2/19 Advocacy at a Glance 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More Advocacy at a Glance 5/10/19 Advocacy at a Glance 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More Advocacy at a Glance 6/22/18 Advocacy at a Glance 6/22/18 Still Time to Join the Alliance’s Sign-on Letter in Support of FDA Funding Read More Advocacy at a Glance 7/21/17 Advocacy at a Glance 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More Analysis and Commentary 4/28/17 Analysis and Commentary 4/28/17 Success ... But More Work Will Be Needed! Read More Advocacy at a Glance 3/19/16 Advocacy at a Glance 3/19/16 Alliance Capitol Hill Advocacy Day is a Success and more Read More Advocacy at a Glance 10/9/15 Advocacy at a Glance 10/9/15 Will FSMA Make a Difference and more Read More Analysis and Commentary 9/12/15 Analysis and Commentary 9/12/15 The Emerging Fall Fiscal Cliff and more Read More
Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Advocacy at a Glance 3/19/21 Advocacy at a Glance 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Advocacy at a Glance 10/24/20 Advocacy at a Glance 10/24/20 Washington Is Waiting for the Election Read More
Analysis and Commentary 7/10/20 Analysis and Commentary 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Advocacy at a Glance 7/10/20 Advocacy at a Glance 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More
Advocacy at a Glance 6/26/20 Advocacy at a Glance 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Advocacy at a Glance 4/24/20 Advocacy at a Glance 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More
Analysis and Commentary 4/17/20 Analysis and Commentary 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More
Advocacy at a Glance 4/17/20 Advocacy at a Glance 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More
Advocacy at a Glance 3/27/20 Advocacy at a Glance 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More
Advocacy at a Glance 10/5/19 Advocacy at a Glance 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More
Advocacy at a Glance 8/2/19 Advocacy at a Glance 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More
Advocacy at a Glance 5/10/19 Advocacy at a Glance 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More
Advocacy at a Glance 6/22/18 Advocacy at a Glance 6/22/18 Still Time to Join the Alliance’s Sign-on Letter in Support of FDA Funding Read More
Advocacy at a Glance 7/21/17 Advocacy at a Glance 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More
Analysis and Commentary 4/28/17 Analysis and Commentary 4/28/17 Success ... But More Work Will Be Needed! Read More
Advocacy at a Glance 3/19/16 Advocacy at a Glance 3/19/16 Alliance Capitol Hill Advocacy Day is a Success and more Read More
Advocacy at a Glance 10/9/15 Advocacy at a Glance 10/9/15 Will FSMA Make a Difference and more Read More
Analysis and Commentary 9/12/15 Analysis and Commentary 9/12/15 The Emerging Fall Fiscal Cliff and more Read More
